International Journal of Health and Clinical Research

Yazarlar: Subham Das, Abheek Das, Manish Kumar Prasad, Rakhi Sanyal, Sukanta Sen

Konular:-

Anahtar Kelimeler:Drug promotional literature (DPL),IFMPA,WHO guidelines,Pharmaceutical company,Safety information

Özet: Background: Drug promotional literatures (DPL) distributed by various pharmaceutical companies are frequently reported to be inaccurate and not adhering to the relevant guidelines. The objective of the study was to evaluate various drug promotional literatures using criteria advocated by various national and global guidelines. Methods: This observational study was conducted with diverse DPLs collected from various OPDs using the World Health Organization and other guidelines. Results: Out of total 560 DPLs evaluated, majority of them were found to be lacking in adequate and accurate information with regard to various criteria like dosage, dosage schedule, adjuvants used, safety information and pharmaceutical safety data. Conclusion: Majority of the DPLs did not adhere to the ethical guidelines issued by any company and requires strict administrative monitoring. Prescribers also need to exercise utmost caution in believing those claims mentioned and judiciously incorporate information mentioned in DPLs.

---